Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06618703

Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years

Endocrine Follow-up After Cerebral Radiotherapy Performed Before Age 16 (Direct Cerebral Field or Following Facial, Cervical or High Ear, Nose, and Throat Radiotherapy)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
230 (estimated)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
4 Years – 18 Years
Healthy volunteers
Not accepted

Summary

BICHE- 1: Brain Irradiation for Childhood cancer - Endocrine monitoring during the first five years is a study of endocrine monitoring after cerebral radiotherapy. The study concerns patients in remission at the end of oncological treatment aged between 4 and 18 years at the time of inclusion and who have had radiotherapy before the age of 16, irradiating all or part of the brain, with a delay between the end of radiotherapy and inclusion of less than 5 years. Patients will be included during a routine visit to the paediatric endocrinologist. The protocol for the Biche 1 study has been designed and discussed in a multidisciplinary and multicentre manner, based on data from the literature and the French reference document (September 2021) "National protocol for diagnosis and care - congenital pituitary deficiency". In this population, the investigators will conduct a descriptive and exploratory study to establish recommendations for medium-term follow-up; to improve screening for endocrine deficiencies affecting the hypothalamic-pituitary axis in order to improve patients' quality of life and state of health; and to better define dose-volume constraints on the axis. The study will also focus on better detection and characterisation of chronic fatigue as a potential sequela of pituitary deficiencies, in particular by means of a questionnaire assessing fatigue (PedsQL Multidimensional Fatigue scale) which will also be systematically administered and completed annually.The expected sample size is 100-150 patients treated for a brain tumour and 60-80 patients treated for another tumour but with an irradiation field covering all or part of the brain.

Conditions

Interventions

TypeNameDescription
RADIATIONBlood sample, urine sample, osteodensitometryBlood sample, urine sample, osteodensitometry

Timeline

Start date
2025-10-10
Primary completion
2030-10-01
Completion
2030-10-01
First posted
2024-10-01
Last updated
2026-04-06

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06618703. Inclusion in this directory is not an endorsement.